0.3450
+0.0137
+(4.14%)
At close: January 10 at 3:57:44 PM EST
0.3450
0.00
(0.00%)
After hours: 7:57:26 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 1 | 2 |
| Avg. Estimate | -0.03 | -0.03 | -0.11 | -0.12 |
| Low Estimate | -0.03 | -0.03 | -0.11 | -0.12 |
| High Estimate | -0.03 | -0.03 | -0.11 | -0.12 |
| Year Ago EPS | -0.05 | -0.03 | -0.16 | -0.11 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | 204k | 295k | 1.18M | 1.35M |
| Low Estimate | 204k | 295k | 1.18M | 1.3M |
| High Estimate | 204k | 295k | 1.18M | 1.4M |
| Year Ago Sales | 204k | 295k | 1.34M | 1.18M |
| Sales Growth (year/est) | 0.00% | 0.00% | -12.04% | 14.16% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.04 | -0.04 | -0.03 | -0.03 |
| EPS Actual | -0.05 | -0.03 | -0.03 | -0.02 |
| Difference | -0.01 | 0.01 | 0 | 0.01 |
| Surprise % | -16.25% | 18.00% | 0.00% | 33.33% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.03 | -0.11 | -0.12 |
| 7 Days Ago | -0.03 | -0.03 | -0.13 | -0.12 |
| 30 Days Ago | -0.03 | -0.03 | -0.13 | -0.12 |
| 60 Days Ago | -0.03 | -0.03 | -0.13 | -0.12 |
| 90 Days Ago | -0.03 | -0.03 | -0.13 | -0.12 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IGC | 35.48% | 8.54% | 32.97% | -9.09% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Maintains | Ascendiant Capital: Buy to Buy | 12/5/2024 |
| Maintains | Ascendiant Capital: Buy to Buy | 9/3/2024 |
| Maintains | Ascendiant Capital: Buy to Buy | 7/29/2024 |
| Initiated | Alliance Global Partners: Buy | 7/17/2024 |
| Reiterates | Ascendiant Capital: Buy to Buy | 6/21/2024 |
Related Tickers
OGEN Oragenics, Inc.
0.3430
+2.82%
APTO Aptose Biosciences Inc.
0.2200
+3.19%
INAB IN8bio, Inc.
0.3233
+3.42%
LYRA Lyra Therapeutics, Inc.
0.1955
-2.59%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4199
+1.21%
VINC Vincerx Pharma, Inc.
0.1901
-1.50%
VTVT vTv Therapeutics Inc.
13.80
-2.06%
SPRB Spruce Biosciences, Inc.
0.3700
-2.63%
AIM AIM ImmunoTech Inc.
0.2150
-0.92%
VIRX Viracta Therapeutics, Inc.
0.1860
-0.91%